Document is current
Any future updates will be listed below
-
Authors
Palmieri, Orazio
Cannarozzi, Anna Lucia
Latiano, Anna
Massimino, Luca
Bossa, Fabrizio
Riva, Matteo
Ungaro, Federica
Guerra, Maria
Di Brina, Anna Laura Pia
Carparelli, Sonia
Fiorino, Gionata
Perri, Francesco
Danese, Silvio
-
Funding
Funding for this research was provided by:
This research was funded by the European Union—Next Generation EU—PNRR M6C2—Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (PNRR-MAD- 2022-12375729)
- License Information
-
More Information
Article History
Received: 1 July 2025
Accepted: 22 September 2025
First Online: 10 December 2025
Declarations
:
: S.D. has served as a speaker, consultant and advisory board member for Schering Plough, Abbott (AbbVie) Laboratories, Merck and Co, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, Alfa Wasserman, Genentech, Grunenthal, Pfizer, AstraZeneca, Novo Nordisk, Vifor and Johnson and Johnson. The other authors declare no potential conflicts of interest.
